Articles
Papers and Presentations
- Boston Merchant Financial
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- Boston Mutual Funds Exchange
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- Bradenton Herald
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- BusinessRockford.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- CBS 5.com San Francisco
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- CBS3 Philly - ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- CBS4Denver
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- CBSNews.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- CNET News
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- Cablevision/Optonline
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- Carlsbad Current-Argus
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
|
